Company / Net Income
FENNEC PHARMACEUTICALS INC. Net Income History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$436.0K
FY2025
5-year range
-$23.7M / -$436.0K
FY2021-FY2025
Trend
+97.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$24M in FY2023 to $2M in FY2014.
Based on SEC 10-K filings.
-$436,000 in FY2025.
Improved from -$24M to -$436,000 over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 97.3% year-over-year.
- Peak net income was recorded in FY2014.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$436.0K | +97.3% |
| FY2024 | -$16.0M | +32.3% |
| FY2023 | -$23.7M | -31.0% |
| FY2021 | -$18.1M | -83.1% |
| FY2019 | -$9.9M | -40.3% |
| FY2018 | -$7.0M | -152.6% |
| FY2017 | -$2.8M | -323.2% |
| FY2016 | -$659.0K | +69.7% |
| FY2015 | -$2.2M | -217.9% |
| FY2014 | $1.8M | +5086.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026